COMMONWEALTH OF AUSTRALIA

Instrument number PB 2 of 2010

Amendment determination under subsections 85AB(1) and 85AC(1) of the National Health Act 1953

I, FELICITY McNEILL, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 85AB(1) and 85AC(1) of the National Health Act 1953.

Dated 19 January 2010   

Felicity McNeill

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment Determination – drugs on F1 and drugs in Part A of F2     

1.         Commencement

                This instrument commences on the day after registration.

2.         Amendment of PB 95 of 2007

            Schedule 1 amends PB 95 of 2007.

Schedule 1                           Amendments

[1]       Paragraph 3, Drugs on F2, after “Octreotide”,

 insert:

 “Risedronic acid”,

[2]       Paragraph 3, Drugs on F2, after “Sodium lactate compound”

insert:

, “Tiludronic acid”

[3]       Paragraph 4, Drugs in Part A of F2, after “Octreotide”,

            insert:

                        “Risedronic acid”,

[4]       Paragraph 4, Drugs in Part A of F2, after “Sodium lactate compound”

insert:

, “Tiludronic acid”